Navigation Links
Bisphenol A (BPA) at very low levels can adversely affect developing organs in primates
Date:2/27/2014

COLUMBIA, Mo. Bisphenol A (BPA) is a chemical that is used in a wide variety of consumer products, such as resins used to line metal food and beverage containers, thermal paper store receipts, and dental composites. BPA exhibits hormone-like properties, and exposure of fetuses, infants, children or adults to the chemical has been shown to cause numerous abnormalities, including cancer, as well as reproductive, immune and brain-behavior problems in rodents. Now, researchers at the University of Missouri have determined that daily exposure to very low concentrations of BPA by pregnant females also can cause fetal abnormalities in primates.

"BPA is an endocrine disrupting chemical that has been demonstrated to alter signaling mechanisms involving estrogen, androgen and thyroid hormones," said Frederick vom Saal, Curators Professor of Biological Sciences in the College of Arts and Science at MU. "Previous studies in rodents have demonstrated that maternal exposure to very low doses of BPA can significantly alter fetal development, resulting in a variety of adverse outcomes in the fetus. Our study is one of the first to show this also happens in primates."

Although BPA is considered a toxic chemical in other countries such as Canada, the U.S. has been slow to address the issue, said vom Saal. Until now, most studies involving BPA have been conducted on laboratory mice and rats, leading U.S. regulatory agencies to call for studies in primates. With funding provided by the National Institute of Environmental Health Sciences (NIEHS), a research institute of the National Institutes of Health, vom Saal and his colleagues studied the chemical's blood levels in pregnant female rhesus monkeys and their fetuses, which are considered to be very similar to human fetuses.

After collecting tissue samples, other researchers analyzed the tissues to determine if BPA exposure was harmful to fetal development. Researchers found evidence of significant
'/>"/>

Contact: Jeff Sossamon
sossamonj@missouri.edu
573-882-3346
University of Missouri-Columbia
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Bisphenol A is affecting us at much lower doses than previously thought
2. Harmful effects of bisphenol A proved experimentally
3. Hypnosis therapy shown to decrease fatigue levels in breast cancer patients
4. Low levels of pro-inflammatory agent help cognition in rats
5. GameStop Levels Up To Cherwell Service Management
6. RF Safe List of Lowest Radiation Cell Phones by Specific Absorption Rate (SAR) Levels
7. How to Increase Testosterone Levels Naturally Discussed in New Video by Diet Recommendations
8. In Light of Increased Levels of Personal Stress Over the Holiday Season, Lanahan Insurance Recommends Staying Covered with Health Insurance
9. A New “15 Blood Sugar Control Tips” Article Teaches People How To Control Their Blood Sugar Levels Naturally – V-kool
10. A New “11 Ways To Increase Testosterone” Article Helps Men Boost Testosterone Levels Naturally – V-kool
11. Bilateral Biomet Hip Implants Cause Maryland Man Severe Pain, Elevated Metal Ion Levels, and Revision Surgeries, Alleges Lawsuit Filed by Parker Waichman LLP
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Bisphenol A (BPA) at very low levels can adversely affect developing organs in primates
(Date:8/3/2015)... ... August 03, 2015 , ... ... contract research organisations (CROs) for a slew of benefits, allowing them to gain ... operations, boost quality with cost-effective utilisation of resources, get access to innovation and ...
(Date:8/3/2015)... ... August 03, 2015 , ... Dental practice in Los Angeles ... need. Most people know that general health emergencies, such as broken arms or a ... people know where to turn to during a dental emergency. This is important, because ...
(Date:8/3/2015)... ... August 03, 2015 , ... AxoGen, Inc. (NASDAQ: AXGN), a leader ... present at the Wedbush Healthcare Conference on Wednesday, August 12, 2015 at 9:45am (ET) ... archived replay of the Company’s presentation may be accessed via the investor relations section ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... A July ... Injection of Stem Cells Found to Release Natural Painkiller That Can Last 'For Five ... patients. According to the report, the new study showed that harvesting stem cell-rich bone ...
(Date:8/3/2015)... ... August 03, 2015 , ... Constantin Vasilica, 48 from Romania wanted to ... by diabetes after many years of suffering and using medications with strong side effects. ... to ask for extra time off or wait longer hours in the waiting rooms. ...
Breaking Medicine News(10 mins):Health News:Global CRO Market Space Reviewed by Aniruddha Sowale in In-demand Research Report Available at MarketPublishers.com 2Health News:Global CRO Market Space Reviewed by Aniruddha Sowale in In-demand Research Report Available at MarketPublishers.com 3Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 2Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 3Health News:AxoGen, Inc. to Present at the Wedbush Healthcare Conference 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 3
... Introduces New Educational ... Resource at IDSA Annual Meeting, HADDON HEIGHTS, ... a new continuing education,resource as part of their exhibit booth ... America (IDSA), October 4-7, in San Diego,California. Project CDAD: Outbreak ...
... reveal new ways of controlling and treating breast cancer ... today (Monday 1 October 2007). , Dr Robert Clarke ... group have been investigating human breast cancers for the ... tumours and can cause the cancer to recur - ...
... CHICAGO, Oct. 1 Y-ME Illinois will host a ... and,friends. The BIG Night Out - Indulgence for ... 6:30 p.m. to 10:00 p.m. in the Great Hall ... pamper themselves by,partaking in indulgences such as onsite spa ...
... Oct. 1 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals,Corp. today ... signed amended,agreements with Smith & Nephew wound ... dressings with SILCRYST(TM) nanocrystalline coatings.,The two companies ... when Smith &,Nephew bought the Acticoat(TM) brand ...
... WINDSOR, Conn., Oct. 1 UTC Power, a,United ... announced it has,acquired Dome- Tech Group, a national ... New York City. Financial terms were not disclosed. ... energy costs,and improve overall efficiency. It facilitates green, ...
... Achieve Optimum Health, SOMERSET, N.J., Oct. 1 ... announced that it has launched a fourth business,segment, ... pharmaceutical,companies and healthcare payors achieve the best possible ... and stay on the right therapy, everyone wins ...
Cached Medicine News:Health News:National Experts Team Up to Help Hospitals Prevent and Control C. difficile Outbreaks 2Health News:Manchester researchers announce new methods of beating breast cancer 2Health News:Y-ME Illinois Hosts the First-Ever 'BIG Night Out' - Indulgence for a Cause 2Health News:NUCRYST and Smith & Nephew Revise Agreements 2Health News:NUCRYST and Smith & Nephew Revise Agreements 3Health News:NUCRYST and Smith & Nephew Revise Agreements 4Health News:NUCRYST and Smith & Nephew Revise Agreements 5Health News:NUCRYST and Smith & Nephew Revise Agreements 6Health News:NUCRYST and Smith & Nephew Revise Agreements 7Health News:UTC Power Acquires Dome-Tech Group 2Health News:inVentiv Health Launches Fourth Business Segment: inVentiv Patient Outcomes 2Health News:inVentiv Health Launches Fourth Business Segment: inVentiv Patient Outcomes 3
(Date:8/3/2015)... 3, 2015  Array BioPharma Inc. (NASDAQ: ... quarter and full year of its fiscal year ... Chief Executive Officer of Array, noted, "Binimetinib and encorafenib, ... on track for regulatory submissions in 2016. Additional ... and BRAF-mutant colorectal cancer further validate the value ...
(Date:8/3/2015)... Aug. 3, 2015  Charleston Laboratories, Inc., an ... second clinical development program with a Phase 1 ... CL-H1T contains fast-dissolving promethazine and sumatriptan.  ... a treatment for migraine headache pain and migraine-induced ... patients with migraine headaches also suffer from nausea ...
(Date:8/3/2015)... FLORHAM PARK, N.J. , Aug. 3, ... met its primary and secondary endpoints in a phase ... constipation (OIC) in adult patients with chronic non-cancer pain. ... antagonist (PAMORA). This is the third Phase III trial ... endpoints. Study results showed that a 0.2 ...
Breaking Medicine Technology:Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 2Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 3Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 4Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 5Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 6Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 7Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 8Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 9Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 10Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 11Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 12Charleston Laboratories, Inc. Initiates Patient Enrollment in a Phase 1 Study of Charleston's Second Product, CL-H1T 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 4
... /PRNewswire-Asia/ -- Simcere Pharmaceutical Group (NYSE: SCR ... specializing in the development, manufacturing, and marketing of branded ... annual general meeting of shareholders (the "Meeting") will be ... Beijing time. The meeting will be held at No.699-18, ...
... /PRNewswire-iReach/ -- Global Information Inc. is pleased to ... Therapy market: Global Protein Therapeutics Market ... become one of the most effective clinical methods to ... metabolic disorders. While worldwide healthcare spending has decline in the ...
Cached Medicine Technology:Simcere Pharmaceutical Group Provides Notice of Annual General Meeting 2New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015 2
... a powerful, compact and programmable 8-channel ... dispensing pumps. Dispense and aspirate head ... horizontal needle positioning in the well. ... waste bottles and vacuum sensing allow ...
... is a solid made, manual plate ... valves for dispense and aspirate function ... complete with a stand and all ... be used, as well as any ...
... of microplate washers are precise, fast and ... manifold, providing independent control of both dispense ... and overflow protection in both 96- and ... the most precise and reliable washer available ...
... The Microplate washer MP-1200 is ... microplate washing system. Its internal micropumps ... and to discharge from all types ... microplate to be washed in rows ...
Medicine Products: